SEC Form 4 · accession 0001209191-18-025436
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Spector
Officer — EVP, General Counsel & Sec
Period of report
Apr 16, 2018
Accepted (ET)
Apr 18, 2018 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 16, 2018 | M | 15,001 | $17.90 | A | 34,691 | D | |
| Common Stock | Apr 16, 2018 | M | 15,000 | $18.10 | A | 49,691 | D | |
| Common StockF2 | Apr 16, 2018 | S | 20,901 | $34.3264 | D | 28,790 | D | |
| Common StockF3 | Apr 16, 2018 | S | 7,700 | $34.9957 | D | 21,090 | D | |
| Common StockF4 | Apr 16, 2018 | S | 1,400 | $35.8107 | D | 19,690 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $17.90 | Apr 16, 2018 | M | 15,001 | D | — | Dec 15, 2022 | Common Stock | 15,001 | 14,999 | D |
| Employee Stock Option (right to buy)F6 | $18.10 | Apr 16, 2018 | M | 15,000 | D | — | Mar 19, 2022 | Common Stock | 15,000 | 34,530 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.77 to $34.76, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.77 to $35.63, inclusive.
- F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.80 to $35.84, inclusive.
- F5The options vest in four equal annual installments and are exercisable once vested. The first and second installments became exercisable on December 15, 2016 and 2017, and the third and fourth installments vest on December 15, 2018 and 2019.
- F6The options vested in four equal annual installments on March 19, 2013, 2014, 2015 and 2016, and were immediately exercisable once vested.